Market Cap : 8.28 B | Enterprise Value : 6.99 B | P/E (TTM) : 123.31 | P/B : 5.98 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ionis Pharmaceuticals's enterprise value is $6,990.8 Mil. Ionis Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was $155.4 Mil. Therefore, Ionis Pharmaceuticals's EV-to-EBITDA for today is 44.99.
During the past 13 years, the highest EV-to-EBITDA of Ionis Pharmaceuticals was 380.10. The lowest was -3251.20. And the median was -13.00.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2021-01-28), Ionis Pharmaceuticals's stock price is $59.190000. Ionis Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was $0.48. Therefore, Ionis Pharmaceuticals's PE Ratio for today is 123.31.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
* The bar in red indicates where Ionis Pharmaceuticals's EV-to-EBITDA falls into.
Ionis Pharmaceuticals's EV-to-EBITDA for today is calculated as:
EV-to-EBITDA | = | Enterprise Value (Today) | / | EBITDA (TTM) |
= | 6990.826 | / | 155.393 | |
= | 44.99 |
Ionis Pharmaceuticals's current Enterprise Value is $6,990.8 Mil.
Ionis Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Sep. 2020 was 255.702 (Dec. 2019 ) + -46.635 (Mar. 2020 ) + -29.004 (Jun. 2020 ) + -24.67 (Sep. 2020 ) = $155.4 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Ionis Pharmaceuticals's PE Ratio for today is calculated as:
PE Ratio | = | Share Price (Today) | / | Earnings per Share (Diluted) (TTM) |
= | 59.190000 | / | 0.48 | |
= | 123.31 |
Ionis Pharmaceuticals's share price for today is $59.190000.
Ionis Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2020 was 1.28 (Dec. 2019 ) + -0.35 (Mar. 2020 ) + -0.23 (Jun. 2020 ) + -0.22 (Sep. 2020 ) = $0.48.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Please read Which price ratio outperforms the enterprise multiple?
No Headline